Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Raymond

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Brain Research. Molecular Brain Research|May 17, 2005
Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brainVânia D'Almeida, Débora C Hipólide, Roger Raymond, et al.
Journal of Psychopharmacology (Oxford, England)|April 28, 2021
Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent ratsShannon C Waye, O Chandani Dinesh, Sm Nageeb Hasan, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 11, 2019
A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant ResponseFrancis Rodriguez Bambico, Zhuoliang Li, Meaghan Creed, et al.
Bioorganic & Medicinal Chemistry|May 29, 2013
Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolaseOleg Sadovski, Justin W Hicks, Jun Parkes, et al.
Biological Psychiatry|October 13, 2009
Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in ratsClement Hamani, Mustansir Diwan, Carlos E Macedo, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Psychopharmacology|January 4, 2022
Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3Mina G Nashed, Shannon Waye, S M Nageeb Hasan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2026
SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis studyPou Hong Justin Chia, Takuya Toyonaga, Junchao Tong, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2021
Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older AdultsSusmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, et al.
Pharmacotherapy|May 6, 2025
Relationship of the revised anticholinergic drug scale with cultured cell-based serum anticholinergic activity and cognitive measures in older adults with mild cognitive impairment or remitted depressionRyan M Carnahan, Susmita Chandramouleeshwaran, Naba Ahsan, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Brain Research. Molecular Brain Research|May 17, 2005
Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brainVânia D'Almeida, Débora C Hipólide, Roger Raymond, et al.
Journal of Psychopharmacology (Oxford, England)|April 28, 2021
Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent ratsShannon C Waye, O Chandani Dinesh, Sm Nageeb Hasan, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 11, 2019
A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant ResponseFrancis Rodriguez Bambico, Zhuoliang Li, Meaghan Creed, et al.
Bioorganic & Medicinal Chemistry|May 29, 2013
Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolaseOleg Sadovski, Justin W Hicks, Jun Parkes, et al.
Biological Psychiatry|October 13, 2009
Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in ratsClement Hamani, Mustansir Diwan, Carlos E Macedo, et al.
Synapse (New York, N.Y.)|June 3, 2009
In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic miceEugenii A Rabiner, Mark Slifstein, Jose Nobrega, et al.
Psychopharmacology|January 4, 2022
Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3Mina G Nashed, Shannon Waye, S M Nageeb Hasan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2026
SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis studyPou Hong Justin Chia, Takuya Toyonaga, Junchao Tong, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 13, 2021
Relationships Between a New Cultured Cell-Based Serum Anticholinergic Activity Assay and Anticholinergic Burden Scales or Cognitive Performance in Older AdultsSusmita Chandramouleeshwaran, Naba Ahsan, Roger Raymond, et al.
Pharmacotherapy|May 6, 2025
Relationship of the revised anticholinergic drug scale with cultured cell-based serum anticholinergic activity and cognitive measures in older adults with mild cognitive impairment or remitted depressionRyan M Carnahan, Susmita Chandramouleeshwaran, Naba Ahsan, et al.
Pageof 3